Additionally, by reducing the expression of NK cell activation receptor ligands (such as NKG2D and DNAM-1) on tumor cell surfaces, MDM2 suppresses p53 function, which diminishes NK cell-mediated osteosarcoma cells eradication. Here, TP53 is linked to neoplasm.